Understanding Medulloblastoma Brain Cancer

Medulloblastoma brain cancer is a type of tumor that starts in the brain and spinal cord, specifically in a part of the brain called the cerebellum, which is located at the back of the brain and is important for balance and coordination.

While it can occur in children and adults, medulloblastoma is the most common brain tumor in children. It’s a type of central nervous system (CNS) tumor, meaning it affects the brain or spinal cord. Understanding medulloblastoma, its characteristics, how it’s treated, and what the outlook is can be helpful for families facing this diagnosis.

What is Medulloblastoma?

Medulloblastoma is a tumor made up of cancer cells that develop in the cerebellum. These cells can grow quickly and, if not treated, can spread to other areas of the brain and spine through the cerebrospinal fluid (CSF), the liquid that surrounds and protects these vital structures. Because of its potential to spread within the central nervous system, prompt and effective treatment for medulloblastoma is crucial.

While it’s primarily known as a childhood cancer, medulloblastoma can also occur in adults, although it’s much less common. The way it’s treated and the prognosis can sometimes differ between children and adults.

Who is Affected by Medulloblastoma?

As mentioned, medulloblastoma is most often diagnosed in children, with the peak incidence occurring between the ages of 3 and 9 years. It accounts for about 15-20% of all childhood brain tumors. While less frequent in adults, it can still occur, representing less than 1% of adult brain tumors in the united states.

Certain genetic conditions can increase the risk of developing medulloblastoma. These include:

Gorlin Syndrome (also known as nevoid basal cell carcinoma syndrome): A condition that increases the risk of various cancers, including medulloblastoma.
Turcot Syndrome: Another genetic disorder that can increase the risk of brain tumors, including medulloblastoma, as well as colon cancer.

If a child or adult has one of these syndromes, doctors may recommend more frequent check-ups and screenings.

Types of Medulloblastoma

Researchers have identified different subtypes of medulloblastoma based on their genetic and molecular characteristics. These subtypes can behave differently and may respond differently to treatment for medulloblastoma. The main subtypes include:

WNT: Often has a better prognosis.
SHH (Sonic Hedgehog): Can occur in both children and adults and has varying outcomes depending on the patient’s age and specific genetic features.
Group 3: Often considered high risk and can be more challenging to treat.
Group 4: The most common subtype and can have varying outcomes.

Identifying the specific subtype of medulloblastoma is an important part of planning the treatment for medulloblastoma and understanding the potential prognosis.

Symptoms of Medulloblastoma

The symptoms of medulloblastoma can vary depending on the size and location of the tumor and whether it has spread. Common symptoms, especially in children, may include:

Headaches, often worse in the morning.
Nausea and vomiting.
Balance problems and difficulty walking.
Clumsiness or lack of coordination.
Dizziness.
Double vision or other vision changes.
Fatigue or decreased energy.
In some cases, symptoms of increased pressure in the skull, such as irritability or changes in head size (in infants).

A thorough neurological exam is crucial when someone presents with these types of symptoms. This exam helps doctors assess brain function, including balance, coordination, vision, hearing, and reflexes.

Diagnosis of Medulloblastoma

Diagnosing medulloblastoma involves several steps:

Neurological Exam: As mentioned, this helps assess the patient’s nervous system function.

Imaging Tests:Magnetic Resonance Imaging (MRI) of the brain and spine: MRI is the primary imaging test used to diagnose medulloblastoma. It provides detailed pictures of the brain and spine and can show the size and location of the tumor, as well as if it has spread.
Computed Tomography (CT) scan: A CT scan may be used in some cases, especially if MRI is not immediately available, but MRI provides more detailed images of the soft tissues of the brain and spine.

Lumbar Puncture (Spinal Tap): A lumbar puncture is often performed to collect a sample of the cerebrospinal fluid. This sample is examined under a microscope to look for cancer cells that may have spread from the original tumor.
Biopsy: A tissue sample from the tumor is needed to confirm the diagnosis of medulloblastoma and determine its subtype. The biopsy is usually obtained during the surgical removal of the tumor.
Molecular and Genetic Testing: The tumor tissue is also analyzed for specific genetic and molecular markers, which helps in classifying the subtype of medulloblastoma and can provide important information about prognosis and potential response to different treatments.

Treatment for Medulloblastoma

The treatment for medulloblastoma typically involves a combination of different approaches, tailored to the individual patient, the subtype of the tumor, the extent of the spread, and the patient’s age. The main treatment for medulloblastoma modalities include:

Surgical Removal of the Tumor: The first goal is usually to surgical removal of the tumor as much as safely possible. This helps to relieve pressure in the skull and remove the bulk of the cancer cells.
Radiation Therapy: Radiation therapy to the brain and spine is a standard part of the treatment for medulloblastoma, especially when there is a high risk of the tumor spreading or recurring. The specific type and dose of radiation therapy depend on the patient’s age and the extent of the disease. Techniques like craniospinal irradiation (CSI) are often used to treat the entire brain and spine.
Chemotherapy: Chemotherapy, using drugs to kill cancer cells, is also a key component of the treatment for medulloblastoma. It can be given before, during, or after radiation therapy. Different chemotherapy regimens are used depending on the patient’s age and the risk group of the medulloblastoma.
High-Dose Chemotherapy with Stem Cell Transplant: For some high risk medulloblastomas that have recurred, high-dose chemotherapy followed by a stem cell transplant may be an option. This allows doctors to use very strong chemotherapy drugs, with the patient’s own or donor stem cells given back to help the bone marrow recover.

Risk Stratification in Medulloblastoma

Doctors often classify medulloblastoma into different risk groups (standard risk and high risk) based on factors like the amount of tumor remaining after surgery and whether the tumor has spread. This risk stratification helps guide the intensity of the treatment for medulloblastoma. Patients with high risk medulloblastoma typically require more intensive therapy.

Prognosis and Long-Term Outlook

The prognosis for medulloblastoma has improved significantly over the past few decades due to advances in diagnosis and treatment. However, it can vary widely depending on several factors including the patient’s age, the subtype of medulloblastoma, the extent of the tumor spread at diagnosis, and how well the tumor responds to treatment for medulloblastoma.

Children with standard-risk medulloblastoma often have a good chance of long-term survival. The prognosis for high risk medulloblastoma can be more challenging. Adults with medulloblastoma tend to have outcomes that are somewhere between those of standard-risk and high risk childhood medulloblastoma.

Long term follow-up care is essential for all medulloblastoma survivors to monitor for recurrence and manage any long term side effects from the treatment for medulloblastoma, such as neurological problems, learning difficulties, or hormonal issues.

The Role of Clinical Trials

Clinical trials play a vital role in improving the treatment for medulloblastoma. These research studies test new drugs, therapies, and approaches to care. Patients with medulloblastoma, especially those with high risk or recurrent disease, may want to consider participating in clinical trials to access the most cutting-edge treatments.

Medulloblastoma brain cancer, while most common in children, is a serious condition that requires a comprehensive and multidisciplinary approach to treatment for medulloblastoma.

Understanding the different subtypes, the importance of surgical removal of the tumor, radiation therapy, and chemotherapy, as well as the role of clinical trials, is crucial for families and patients facing this diagnosis.

While the journey can be challenging, advances in research and treatment continue to improve the long term outcomes for individuals with medulloblastoma.

Learn how you can make a difference by visiting our Donate page.

If you’d like to contribute your time and skills, please visit our Volunteer page.

For those in need of financial assistance during their cancer journey, you can find more information on our Financial Assistance page.